Back to Endocrinology
Endocrinologyv1999Evidence-Based

Dutch Criteria for Familial Hypercholesterolemia (FH)

Diagnoses familial hypercholesterolemia (FH) based on clinical, genetic, and family history using the Dutch Lipid Clinic Network (DLCN) point-based scoring system. Provides stratification into possible, probable, or definite FH categories.

Clinical Input Parameters

mmol/L
Range: 0 — 30 mmol/L
Clinical Assessment
Awaiting Parameters
dutch fh score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Dutch Criteria for Familial Hypercholesterolemia (FH) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within endocrinology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Points awarded for: LDL cholesterol levels (1-8 points based on level), tendon xanthomas (6 points), corneal arcus <45 years (4 points), family history of elevated LDL (1 point), family history of premature CHD (1 point), personal premature CHD (2 points), personal premature CVD (1 point), positive DNA analysis (8 points). Scoring: 0-2 points = Unlikely FH, 3-5 points = Possible FH, 6-7 points = Probable FH, ≥8 points = Definite FH.

Clinical Pearls & Practice Notes

  • Developed by the Dutch Lipid Clinic Network in 1999 as a comprehensive diagnostic tool for FH.
  • Point-based scoring system allows for graduated likelihood assessment rather than binary diagnosis.
  • Widely recommended by international guidelines including ESC/EAS and NLA recommendations.
  • More comprehensive than Simon Broome criteria by including weighted scoring system.
  • LDL cholesterol thresholds: ≥8.5 mmol/L = 8 points; 6.5-8.4 = 5 points; 5.0-6.4 = 3 points; 4.0-4.9 = 1 point.
  • Tendon xanthomas are pathognomonic for FH and receive highest individual point value (6 points).
  • Corneal arcus in patients <45 years is highly suggestive of FH (4 points).
  • Family history components recognize the autosomal dominant inheritance pattern of FH.
  • DNA analysis provides definitive diagnosis when positive (8 points for pathogenic mutation).
  • Cascade screening is mandatory for all first-degree relatives of diagnosed FH patients.
  • Early diagnosis and treatment can prevent premature cardiovascular disease in FH patients.
  • High-intensity statin therapy is first-line treatment with LDL goal <1.8 mmol/L (70 mg/dL).
  • Combination therapy often required to achieve target LDL levels in FH patients.
  • Genetic counseling recommended for patients with confirmed FH diagnosis.
  • Prevalence of heterozygous FH is approximately 1 in 250-500 individuals worldwide.

Evidence & Literature Citations

  1. The diagnosis and management of familial hypercholesterolaemia. Dutch Health Care Insurance Board. 1999. Available from: https://www.lipidclinic.org/
  2. Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013;34(45):3478-90a. doi: 10.1093/eurheartj/eht273.
  3. Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA, et al. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J. 2014;35(32):2146-57. doi: 10.1093/eurheartj/ehu274.

Score Interpretation Ranges

Unlikely FH0 – 2 pts

FH unlikely

Possible FH3 – 5 pts

Possible familial hypercholesterolemia

Probable FH6 – 7 pts

Probable familial hypercholesterolemia

Definite FH8 – 15 pts

Definite familial hypercholesterolemia

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.